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to any cell line or
tissue of interestCytoplasmic extracts from unfertilized Xenopus eggs have made important contributions to our
understanding of microtubule dynamics, spindle assembly, and scaling. Until recently, these in
vitro studies relied on the use of heterologous tubulin. This protocol allows for the purification of
physiologically relevant Xenopus tubulins in milligram yield, which are a complex mixture of
isoforms with various post-translational modifications. The protocol is applicable to any cell or
tissue of interest.Reusch et al., STAR Protocols
1, 100151
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Cytoplasmic extracts fromunfertilizedXenopuseggshavemade important contribu-
tions to our understanding of microtubule dynamics, spindle assembly, and scaling.
Until recently, these in vitro studies relied on the use of heterologous tubulin. This
protocol allows for the purification of physiologically relevant Xenopus tubulins in
milligram yield, which are a complex mixture of isoforms with various post-transla-
tional modifications. The protocol is applicable to any cell or tissue of interest.
For complete details on the use and execution of this protocol, please refer to
Hirst et al. (2020).BEFORE YOU BEGIN
Injection of Xenopus Frogs to Induce Egg Laying
Timing: 1–2 h for injections and frog handling (will depend on the number of frogs),
1–5 days prior to tubulin purification
The basic protocol is based on AndrewMurray’s original protocol for Xenopus laevis (X.l.) eggs (Mur-
ray 1991) with minor modifications for X. tropicalis (X.t.) (Brown et al., 2007) and X. borealis (X.b.)
(Kitaoka et al., 2018).
Note: Yields of extract and therefore tubulin will depend on egg quantity and size (Table 1).
The eggs of X.l. are 1.3G0.05 mm in diameter, similar to X.b. eggs with a diameter of
1.2G0.02 mm (Kitaoka et al., 2018). In either case, a batch of eggs from one frog will yield
1 mL of extract. The eggs of X.t., however, are significantly smaller (0.75G0.02 mm) and
will thus yield around 0.35 mL per frog. We recommend starting with at least two-three X.l.
or X.b. frogs and six X.t. frogs per experiment.
1. Prepare stock solutions of Pregnant Mare Serum Gonadotrophin (PMSG, 200 U/mL) and Human
Chorionic Gonadotrophin (HCG, 2,000 U/mL or 100 U/mL) by dissolving hormones in ultra-pure
water. Filter-sterilize the stock solution.
Note: We suggest using fresh aliquots of both hormones. For extended storage, store as
single-use aliquots at 20C for a few months only.STAR Protocols 1, 100151, December 18, 2020 ª 2020 The Authors.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1. Tubulin Purification Yields
Species Input Egg Extract Tubulin Yield
Xenopus laevis 3 mL 2.2 mg
Xenopus borealis 2.5 mL 1.4 mg
Xenopus tropicalis 6.5 mL 2.4 mg
ll
OPEN ACCESS Protocol2. At least three days before preparing extracts, prime X.l. and X.b. frogs by injecting them with
100 U and 50 U of PMSG (by diluting the 200 U/mL stock in ultra-pure water), respectively. Primed
X.l. and X.b. can be used for up to 10 days for egg laying after priming. In the case of X.t. frogs,
prime frogs 16–24 h before extract preparation with 10 U of HCG.
CRITICAL: The injected volume should not exceed 0.5 mL for X.l. and X.b., and 0.1 mL forX.t. Gently inject the hormones subcutaneously, dorsally posterior to the lateral line.2
CRITICAL: Do not feed the frogs after priming. Fed frogs often defecate during egglaying, which can impact egg quality and residual debris is often difficult to remove.Note: For the injections, we suggest using sterile 27-G needles and 1 mL syringes.
3. To induce ovulation, boost primed frogs by HCG injection. For X.l., we recommend injecting
1,000 U of HCG per frog 16–18 h before eggs are needed. For X.b., we suggest using 500 U
of HCG per frog 16–24 h before the experiment. For X.t., we recommend a 200 U injection of
HCG per frog given 5–6 h before extract preparation.
4. Separate each frog in an individual container. For X.l. and X.b. frogs, use 1 L of 13MMR and 0.53
MMR, respectively. For X.t., transfer frogs into containers containing a suitable volume (0.5 L) of
tank water (our frogs are kept in recirculating water with controlled temperature, conductivity of
1,000 mS and at pH 7.2–7.5).
5. For the egg laying step, transfer containers with frogs to a dark and quiet environment such as an
incubator maintained at the appropriate temperature (16C–18C for X.l., 16C for X.b. and
25C–27C for X.t.).
Note: For X.t., temperatures below 23C have been reported to impact extract quality (Brown
et al., 2007).
6. Prepare buffers required for extract prep freshly unless mentioned otherwise. Maintain a 16C–
18C working environment for extract preparation.Preparation of the TOG Column
Timing: 2 days
Here, the purification of tubulin takes advantage of the specific binding of TOG domains to tubulin
(Widlund et al., 2011, Widlund et al., 2012). The TOG1/2 domain from Saccharomyces cerevisiae
Stu2 fused to glutathione S-transferase (GST) is expressed as a fusion protein in Escherichia coli
and conjugated to a N-hydroxysuccinimide ester-activated sepharose column (NHS column), which
we then refer to as the TOG column. The TOG domains of S. cerevisiae Stu2 bind to every tubulin we
tested so far. However, if you unexpectedly will not be able to purify your tubulin of choice, you
might consider making a column with the TOG domain of your species of interest. TOG proteins
have been found in all eukaryotes (Gard et al., 2004; Al-Bassam and Chang, 2011). The purification
of X.l. tubulin based on conventional polymerization-depolymerization cycles has been described
elsewhere (Groen and Mitchison 2016).STAR Protocols 1, 100151, December 18, 2020
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7. Transform the TOG1/2 plasmid (pGEX-6P-1 Stu2 1-590) into BL21(DE3) T1 pRARE cells.
8. Inoculate an overnight culture in LB containing antibiotics (100 mg/mL ampicillin and 15 mg/mL
chloramphenicol).
Note: Make sure to use fresh transformants for the expression.
9. Dilute culture 500-fold into 3 L LB with the same antibiotics and shake at 37C until the OD600
reaches 0.5.
Note: A total of 3 L expression culture should yield sufficient GST-TOG1/2 (50–60 mg) to
make a 5 mL TOG column.
10. Shift the cultures to 18C for 1 h.
11. Induce expression with 0.2 mM isopropyl-b-D-1-thiogalactopyranoside (IPTG) and incubate at
18C and 220 rpm orbital rotation overnight.
12. Harvest cells by centrifugation in a JLA 8.1000 rotor (or comparable large volume model) for
5 min at 5,000 rpm (6,200 3 g) at 4C.
Pause Point: At this point the pellet can be flash-frozen and stored at 80C.
13. Resuspend the pellets in a total of 100 mL ice-cold 23 PBS with 1 mM DTT, 20 mL benzonase
(25 U/mL) and 13 protease inhibitors (2 x cOmplete EDTA-free Protease Inhibitor Cocktail tab-
lets per 100 mL).
14. Lyse cells on ice using a high-pressure homogenizer (e.g., Emulsiflex) by passing the cell suspen-
sion through the homogenizer 23 at 1,500 bar.
15. Add NP-40 to a final concentration of 1%.
16. Clarify lysate by a centrifugation step in a JLA 16.250 rotor for 30 min at 16,000 rpm (38,0003 g)
at 4C.
17. Further clarify the supernatant by filtering through a 0.45 mm filter on ice.
Note: From now on work in the cold room.
18. Equilibrate a Glutathione Sepharose High GSTrap HP column (total column volume is 50 mL)
with 100 mL 23 PBS with 1 mM DTT at 5 mL/min.
19. Apply lysate to the GSTrap at 2 mL/min.
20. Wash with 10 column volumes (CV) 23 PBS, 1 mM DTT, 0.1% Tween20 at 10 mL/min.
21. Wash with 2 CV 5 mM ATP with 10 mM MgCl₂ in 23 PBS at 10 mL/min.
22. Incubate for 20 min.
23. Wash again with 2 CV 5 mM ATP with 10 mM MgCl₂ in 23 PBS at 10 mL/min.
24. Wash with 5 CV of 63 PBS and 1 mM DTT at 10 mL/min.
25. Wash with 5 CV of 23 PBS and 1 mM DTT at 10 mL/min.
26. Elute the GST-fusion protein using 5 mM reduced glutathione in 23 PBS and 1 mM DTT at pH
8.0 at 10 mL/min into 12 fractions of 10 mL each.
27. Determine presence of protein by Bradford assay in the elution fractions.
28. Pool peak fractions to a maximum of 100 mL.
29. Dialyze against three changes of 100 mM NaHCO₃ with 100 mM NaCl at pH 8.2 (coupling
buffer).
Note: We do three rounds of dialysis (2 h, overnight, 2 h) with 2 L of coupling buffer each
round.STAR Protocols 1, 100151, December 18, 2020 3
Figure 1. Purification and Coupling Efficiency of GST-TOG1/2
Expressed and purified GST-TOG1/2 (Input) used to make two TOG columns, flowthrough (FT) after conjugation to a
NHS-column one (#1) and two (#2).
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OPEN ACCESS Protocol30. Equilibrate a 15 mL Amicon Ultra-4 concentration column with coupling buffer by spinning it 23
for 3 min at 4,000 rpm (3,220 3 g) in a clinical centrifuge at 2C.
31. Concentrate protein to a final volume of around 5 mL in a clinical centrifuge at 4,000 rpm
(3,220 3 g) at 2C. The final concentration should be around 10 mg/mL.
Note: The expected molecular weight of the purified GST-TOG1/2 is 94 kDa (Figure 1).Conjugation of GST-TOG1/2 to an NHS Column
Note:We use a ‘‘HiTrapNHS-activated HP’’-column with a total column volume of 5 mL and
do the conjugation in a cold room.
32. Activate column with 2 CV freshly prepared ice-cold 1 mM HCl at 1 CV/min.
33. Add MgCl₂ to your concentrated GST-TOG1/2 protein solution, final concentration is 80 mM.
34. Load protein onto the NHS column and incubate for 20–30 min.
35. Wash with 6 CV 0.5 M Ethanolamine and 0.5 M NaCl at pH 8.3 at 1 CV/min to block remaining
reactive groups.
36. Incubate for 30 min.
37. Wash with 10 CV 63 PBS at 1 CV/min.4 STAR Protocols 1, 100151, December 18, 2020
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ing samples before and after loading the protein on the column (Figure 1).
38. Wash with 5 CV 13 PBS with 50% glycerol (storage buffer) at 0.5 CV/min.
39. Store column at 20C in a 50 mL Falcon tube.KEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse monoclonal anti-Tubulin (clone
DM1A)
Sigma-Aldrich Cat #T9026; RRID: AB_477593
Mouse monoclonal anti-Tubulin (clone B-5-
1-2)
Sigma-Aldrich Cat #: T5168; RRID: AB_477579
Tubulin C terminus with tyrosine removed Abcam Cat #: ab48389; RRID: AB_869990
Tyrosinated C terminus of tubulin Abcam Cat #: ab6160; RRID: AB_305328
Acetylated lysine 40 of a-tubulin (clone 6-
11B-1)
Sigma-Aldrich Cat #: T7451; RRID: AB_609894
Phosphorylated serine residues Abcam Cat #: ab9332; RRID: AB_307184
Bacterial Strains
BL21(DE3) T1 pRARE Sigma-Aldrich Cat#: B2935
Chemicals, Peptides, and Recombinant Proteins
cOmplete, EDTA-free Protease Inhibitor
Cocktail
Merck Cat #: 4693132001
Pregnant mare serum gonadotrophin
(PMSG)
MSD, Tiergesundheit Intergonan  240 IU/mL
Human chorionic gonadotrophin (HCG) Sigma-Aldrich Cat #: CG-10
Cytochalasin D Sigma-Aldrich Cat #: C8273
Xenopus laevis egg tubulin Hirst et al., 2020 N/A
Xenopus tropicalis egg tubulin Hirst et al., 2020 N/A
Xenopus borealis egg tubulin This paper N/A
Pluronic F-127 Sigma-Aldrich Cat #: P2443
Piperazine-1,4-bis(2-ethanesulfonic acid)
(PIPES)
Sigma-Aldrich Cat #: P1851
NeutrAvidin Protein Thermo-Fisher Cat #: 31000
k-Casein from bovine milk Sigma-Aldrich Cat #: C0406
Chlorotrimethylsilane (TMCS) Sigma-Aldrich Cat #: 386529
GMPCPP Jena Bioscience Cat #: NU-405L
Protocatechuic Acid (PCA) Sigma-Aldrich Cat #: 03930590
Protocatechuate-3,4-dioxygenase (PCD) Sigma-Aldrich Cat #: P8279
Trolox Sigma-Aldrich Cat #: 238813
Cy3 Mono NHS Ester GE Healthcare Cat #: PA13101
Cy5 Mono NHS Ester GE Healthcare Cat #: PA15101
GTP Sigma-Aldrich Cat #: G8877
ATP Sigma-Aldrich Cat #: A26209
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
EGTA Sigma-Aldrich Cat #: E3889
EDTA Carl Roth Cat #: 8043.1
Sodium hydroxide (NaOH) Carl Roth Cat #: 9356.1
Calcium chloride dihydrate (CaCl₂$2H₂O) Carl Roth Cat #: HN04.3
Leupeptin Sigma-Aldrich Cat #: L2884
Pepstatin A Sigma-Aldrich Cat #: P5318
Chymostatin Sigma-Aldrich Cat #: C7268
Sodium chloride (NaCl) Carl Roth Cat #: HN00.3
Potassium chloride (KCl) Carl Roth Cat #: HN02.3
HEPES Carl Roth Cat #: HN77.5
Sucrose Carl Roth Cat #: 8890.4
Potassium hydroxide (KOH) Carl Roth Cat #: 6751.1
L-Cysteine Carl Roth Cat #: 1693.3
Magnesium chloride hexahydrate
(MgCl₂$6H₂O)
Carl Roth Cat #: HN03.2
Gelatin from porcine skin Sigma-Aldrich Cat #: G1890
Glycerol Carl Roth Cat #: 3783.4
Ammonium sulfate ((NH₄)₂SO₄) Carl Roth Cat #: 3746.1
Bradford reagent Sigma-Aldrich Cat #: B6916
Benzonase Merck Millipore Cat #: 70664
DTT Sigma-Aldrich Cat #: 43815
Ampicillin Carl Roth Cat #: HP62.1
Chloramphenicol Carl Roth Cat #: 3886.2
Isopropyl-b-D-1-thiogalactopyranoside
(IPTG)
Carl Roth Cat #: 2316.3
Tween-20 Sigma-Aldrich Cat #: P1379
Reduced glutathione Sigma-Aldrich Cat #: G4251
Sodium bicarbonate (NaHCO₃) Carl Roth Cat #: HN01.1
Hydrochloric acid (HCl) Carl Roth Cat #: 4625.2
Ethanolamine Sigma-Aldrich Cat #: E9508
NP40 Sigma-Aldrich Cat #: 74385
Critical Commercial Columns and Consumables
TOG1/2-column Widlund et al., 2012 N/A
Glutathione Sepharose High Performance GE Healthcare Cat #: 11555035
HiTrap NHS-activated HP column (5 mL) GE Healthcare Cat #: GE17-0717-01
PD-10 desalting columns GE Healthcare Cat #: 17085101
Amicon Ultra-4 Centrifugal filter unit, 30 kDa
(0.5 mL)
Merck Millipore Cat #: UFC5030
Amicon Ultra-4 Centrifugal filter unit, 30 kDa
(4 mL)
Merck Millipore Cat #: UFC803024
Amicon Ultra-4 Centrifugal filter unit, 30 kDa
(15 mL)
Merck Millipore Cat #: UFC9030
Bottle top filtration unit, 0.22 mm Thermo-Fisher Cat #: 5954520
Syringe filtration unit, 0.45 mm Carl Roth Cat #: KC72.1
(Continued on next page)
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Experimental Models: Organisms/Strains
Xenopus laevis Nasco Cat #: LM00535
Xenopus tropicalis Nasco Cat #: LM00823
Xenopus borealis Nasco Cat #: LM00699
Other - Equipment
Ultra-clear centrifuge tubes for extract
preparation
Beckman Coulter Cat #: 344057
Rubber tube adapter for extract preparation Beckman Coulter Cat #: 870329
Polypropylene tubes for extract preparation Beckman Coulter Cat #: 331374
Polycarbonate ultracentrifuge tubes to clear
extract
Beckmann Coulter Cat #: 355647
1 mL syringe Carl Roth Cat #: H999.1
3 mL syringe Carl Roth Cat #: EP95.1
18G needle Braun Cat #: 4665120
27G needle Braun Cat #: 9186182
Peristaltic pump (REGLO Digital MS-4/8) Ismatec Cat #: ISM834C
Peristaltic pump tubing Gilson Cat #: F117942
Tubing connector to connect peristaltic
pump tubing to the TOG column
Fisher Scientific Cat #: 11300082
Recombinant DNA
pGEX-6P-1 Stu2 1-590 Widlund et al., 2012 Addgene Plasmid #38314
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Preparing Materials/Equipment for Frog Injections and Egg Extract Preparation
For preparing egg extract you will need:
 Syringes (1 mL) and 27G-needles for frog injections
 Stock solution of hormones: PMSG (200 U/mL) and HCG (2,000 U/mL and 200 U/mL)
 Containers with lids to isolate frogs for egg laying
 Incubator to keep frogs at the appropriate temperature and in the dark while egg laying (optional)
 Glass beakers (0.8 or 1 L) for egg collection
 Plastic Pasteur pipette to sort and transfer eggs
 Ultracentrifuge tubes (5 mL, Beckman Coulter Cat #: 344057)
 Forceps
 Polypropylene centrifuge tube (13 mL, Beckman Coulter Cat #: 331374)
 Clinical centrifuge (for example Eppendorf 5810R with S-4-104 rotor) for packing spin
 High-speed centrifuge (e.g., Avanti JXN-26) with swinging bucket rotor (e.g., Beckman JS-13.1)
for crushing spin
 Rubber adapters for high-speed rotor
 Syringe (1 or 2 mL) with 18G-needle for extract collection
 Eppendorf tubes
 Ice bucket with ice
 Box with cut pipette tips to handle the extractStock Solutions for Extract Preparation
Note: An overview of solutions for extract preparation is given in Table 2.STAR Protocols 1, 100151, December 18, 2020 7
Table 2. Xenopus Egg Extract Buffers
Buffer
103 MMR Marc’s Modified Ringer’s, HEPES buffer at
pH 7.8 to collect and wash eggs
203 XB-Salts Stock solution of salts needed to prepare
CSF-XB
CSF-XB Buffer Cytostastic Factor Extract Buffer with XB-
salts, extract buffer
CSG-XB+ CSF-XB Buffer with protease inhibitors
Dejelly Buffer L-Cysteine solution to remove jelly coat from
eggs
ll
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Prepare a stock solution by combining
 19.02 g of EGTA, or
 18.61 g of EDTA
 90 mL of ultra-pure water
Mix with the help of a stir bar. To dissolve either solution, slowly add NaOH to a pH of 8.0. Once the
salt has dissolved adjust the final volume to 100 mL using ultra-pure water. Filter-sterilize or auto-
clave both solutions and store at room temperature.
1 M CaCl2
Prepare stock solution by combining
 14.7 g of CaCl2.2H2O
 90 mL of ultra-pure water
Stir and dissolve with the help of a stir bar. Adjust the final volume to 100 mL using ultra-pure water.
Autoclave and store at room temperature.
1 M MgCl2
Prepare stock solution by combining
 20.33 g of MgCl2.6H2O
 90 mL of ultra-pure water
Stir and dissolve with the help of a stir bar. Adjust the final volume to 100 mL using ultra-pure water.
Autoclave and store at room temperature.
Inhibitor Stocks for Extract Preparation
 Dissolve Cytochalasin D (10 mg/mL) in DMSO. Prepare 25 mL aliquots and store at 20C.
Note: Cytochalasin D is added to cytostatic factor (CSF) extracts to prevent actin polymeriza-
tion. Actin-intact CSF extracts undergo gelation when incubated at room temperature (Field
et al., 2011), which makes them more viscous and harder to work with. Methods for preparing
actin-intact egg extracts are described in (Field et al., 2014, Field et al., 2017).
 Dissolve 1 tablet of cOmplete, EDTA-free Protease Inhibitor Cocktail in 0.5 mL of CSF-XB Buffer.
Store aliquots at 20C for up to 3 months.8 STAR Protocols 1, 100151, December 18, 2020
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 10 mg/mL leupeptin
 10 mg/mL pepstatin A
 10 mg/mL chymostatin
 in DMSO
Prepare 100 mL aliquots and store at 20C.
103 MMR Buffer
103 MMR Buffer contains 1 M NaCl, 20 mM KCl, 10 mM MgCl2, 20 mM CaCl2, 1 mM EDTA, and
50 mM HEPES, at pH 7.8. To prepare a 5 L stock combine:
 292.2 g of NaCl
 7.46 g of KCl
 10.17 g of MgCl2
 11 g CaCl2
 10 mL of the 0.5 M EDTA stock solution
 59.58 g of HEPES
 4.8 L of ultra-pure water
Mix all components with the help of a stir bar. Adjust pH to 7.8 with NaOH. Adjust the final volume to
5 L using ultra-pure water. Store at room temperature for several months.
Note: When preparing a 13 or 0.53 MMR from the 103 stock solution ensure that the pH of the
working solution is still 7.8. Adjust pH with NaOH if required.
203 XB-Salt Solution
203 XB- salt solution contains 2 M KCl, 20 mM MgCl2, and 2 mM CaCl2. To prepare a 1 L stock
combine:
 149.12 g of KCl
 20 mL of the 1 M MgCl2 stock solution
 2 mL of the 1 M CaCl2 stock solution
 0.9 L of ultra-pure water
Mix components with the help of a stir bar. Adjust the final volume to 1 L using ultra-pure water. Fil-
ter-sterilize the solution and store at 4C for several months.
CSF-XB Buffer
We recommend preparing 0.5 L for each batch of laid eggs freshly before the extract prep.
CSF-XB Buffer contains 10 mM HEPES, 50 mM Sucrose, 100 mM KCl, 1 mM MgCl2, 0.1 mM CaCl2
(present in XB-salt solution) and 5 mM EGTA, at pH 7.7. To prepare 1 L of CSF-XB combine:
 2.38 g of HEPES
 17.11 g of Sucrose
 50 mL of the 203 XB-salt solution
 10 mL of the 0.5 M EGTA stock
 0.9 L of ultra-pure water
Mix components with the help of a stir bar. Adjust the pH to 7.7 with KOH and adjust the final volume
to 1 L using ultra-pure water. Store the buffer between 16C–18C in an incubator.STAR Protocols 1, 100151, December 18, 2020 9
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We suggest preparing 50 mL of CSF-XB+ Buffer per batch of eggs by adding protease inhibitors to
CSF-XB Buffer:
 100 mL of the above CSF-XB Buffer
 1 mL of the Protease Inhibitor Cocktail solution.
Alternatives: When using the LPC cocktail. Combine:
 100 mL of CSF-XB Buffer
 100 mL of LPC cocktail
Mix thoroughly.
Dejelly Buffer
We recommend preparing 0.5 L per batch of laid eggs freshly before (maximum 1 h) the extract prep.
Note: The Dejelly Buffer is different for each frog species. X.l. eggs are dejellied using 2% (w/v)
Cysteine in 0.253 MMR, X.b. eggs using 3% Cysteine in 0.253 MMR and X.t. using 3%
Cysteine with no salt.
 20 g of L-Cysteine for a 2% solution (X.l.), or 30 g of L-Cysteine for a 3% solution (X.b., X.t.)
 25 mL of 103 MMR Buffer (X.l., X.b.) or water (X.t.)
 0.9 L of ultra-pure water
Mix components with the help of a stir bar. Adjust the pH to 7.8 with NaOH and adjust the final vol-
ume to 1 L using ultra-pure water. Store the buffer between 16C–18C in an incubator.
Preparing Materials/Equipment for Affinity Purification of Tubulin
To clear the egg extract before loading it onto the TOG column, you will need:
 High-speed centrifuge (e.g., Beckman Coulter Optima Max-XP) with a fixed-angle rotor
(e.g., Beckman MLA-80)
 Polycarbonate ultracentrifuge tubes (6.5 mL, Beckman Coulter Cat #: 355647)
To assemble the purification setup in the cold room, you will need;
 Peristaltic pump (e.g., REGLO Digital MS-4/8)
 Peristaltic pump tubing
 Tubing connector to connect tubing to the TOG column
 Glass beaker to collect liquid waste
 PD-10 desalting columns
 Pipette boy
 Serological pipettes (10 mL)
 Labeled Eppendorf tubes for taking SDS-PAGE and western blot samples and for collecting
fractions
 Laemmli sample buffer for SDS-PAGE and western blot samples
 Set of pipettes and filter-tips
 Tube racks
Stock Solutions and Buffers for Tubulin Purification
Note: An overview of stock solutions and buffers for tubulin purification is given in Table 3.10 STAR Protocols 1, 100151, December 18, 2020
Table 3. Tubulin Purification Buffers
Buffer
13 BRB80 The only buffer tubulin is happy in
Wash buffer 13 BRB80 with GTP to reduce binding of
unspecific proteins
ATP Wash Buffer 13 BRB80 with ATP to remove chaperones
Elution Buffer High-salt buffer to elute tubulin off the TOG
domains
Desalting Buffer 13 BRB80 with GTP, also tubulin storage
buffer
Column Storage Buffer Glycerol in PBS allows the TOG column to be
stored at 20C
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 1.54 g DTT
 10 mL ultra-pure water
Store 100 mL aliquots at 20C.
1 M MgCl2
Prepare stock solution by combining
 10.15 g of MgCl2,6H2O
 45 mL of ultra-pure water
Stir and dissolve with the help of a stir bar. Adjust the final volume to 50 mL using ultra-pure water.
Filter through a 0.45 mm filter and store at 4C.
0.5 M EGTA
Prepare a stock solution by combining
 3.8 g of EGTA
 15 mL of ultra-pure water
Mix with the help of a stir bar. To dissolve the solution, slowly add NaOH to a pH of 8.0. Once the salt
has dissolved adjust the final volume to 20 mL using ultra-pure water. Filter-sterilize through a
0.45 mm filter and store at 4C.
100 mM GTP
 0.52 g Guanosine 50-triphosphate (GTP) sodium salt hydrate
 7 mL ultra-pure water
Mix at room temperature and adjust to pH 7.0 with NaOH. Use 1 M NaOH until the pH reaches 6.5,
then add 0.1 M NaOH slowly until the pH reaches 7.0. Add ultra-pure water to a final volume of
10 mL, distribute into single-use aliquots (500 mL) and freeze at 20C.
100 mM Mg2+ATP
 0.55 g Adenosine 50-triphosphate (ATP) disodium salt hydrate
 8.5 mL ultra-pure waterSTAR Protocols 1, 100151, December 18, 2020 11
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Adjust to pH 7.0 with NaOH. Use 1 M NaOH until the pH reaches 6.5, then add 0.1 M NaOH slowly
until the pH reaches 7.0. Add ultra-pure water to a final volume of 10 mL, aliquot into single-use vol-
umes of 1 mL and freeze at 20C.
Note: These nucleotides undergo rapid hydrolysis at acidic pH, therefore monitor pH using a
small-volume pH probe while dissolving and keep pH close to neutral. The GTP solution
should be made without Mg2+, which will cause precipitation.
13 BRB80
13 BRB80 buffer contains 80 mM PIPES, 1 mMMgCl2, and 1 mM EGTA, pH 6.9. To prepare 500 mL
of 13 BRB80 buffer, combine:
 12.1 g of PIPES
 1 mL of 0.5 M EGTA
 500 mL of 1 M MgCl2
 8 mL of 10 M KOH
 450 mL of ultra-pure water
Stir the PIPES, adjust the pH to 6.9 using 10 M KOH and then adjust the final volume to 500 mL with
ultra-pure water. PIPES will only dissolve while adjusting pH. Next, filter through a 0.22 mm filter and
store the buffer at 4C. We prepare 13 BRB80 the day before the tubulin purification.
Optional: Alternatively, you can prepare a 53 stock of BRB80 and keep it at 20C for longer
periods of time until the day of the tubulin purification. After thawing, make sure the pH is 6.9.
CRITICAL: The following buffers are prepared shortly before starting the tubulin purifica-tion and kept on ice at all times. ATP and GTP are kept on ice and added to the buffers
shortly before use.Wash Buffer
Wash buffer contains 13 BRB80 and 100 mM GTP.
 200 mL 13 BRB80
 200 mL 100 mM GTP
Mix by inverting.
ATP Wash Buffer
ATP wash buffer contains 13 BRB80, 100 mM GTP, 10 mM MgCl2 and 5 mM Mg
2+ATP.
 37.56 mL 13 BRB80
 40 mL 100 mM GTP
 400 mL 1 M MgCl2
 2 mL 100 mM Mg2+ATP
Mix by inverting.
Elution Buffer
Elution buffer contains 13 BRB80, 100 mM GTP and 500 mM Ammonium sulfate.
 30 mL 13 BRB8012 STAR Protocols 1, 100151, December 18, 2020
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 2 g Ammonium sulfate
Mix by inverting and make sure that the Ammonium sulfate is completely dissolved. Make sure the
pH is 6.9.
Desalting Buffer
This is the final tubulin storage buffer, which contains 13 BRB80 and 10 mM GTP.
 100 mL 13 BRB80
 10 mL 100 mM GTP
Mix by inverting.
Column Storage Buffer
 25 mL 13 PBS
 25 mL glycerol
Mix by inverting and make sure there are no air bubbles in the buffer before using it on the TOG
column.Experimental Model and Subject Details
The Xenopus frogs (adult females) used in this study are part of the Xenopus colony maintained at
the animal husbandry of the Humboldt-Universität zu Berlin. Mature X. laevis, X. tropicalis and
X. borealis frogs were obtained from NASCO (Fort Atkinson, WI). Xenopus frogs were maintained
in a recirculating tank system with regularly monitored temperature and water quality (pH, conduc-
tivity, and nitrate/nitrite levels). X. laevis were housed at a temperature of 18C–20C, X. tropicalis
were housed at 23C–26C, and X. borealis were housed at 21C–23C. Frogs were fed with food
pellets (V7106-0202) from ssniff Spezialdiäten GmbH. All experimental protocols involving frogs
were performed in accordance with national regulatory standards and ethical rules and reviewed
and approved by the LaGeSo under Reg.-Nr. 0096/15.STEP-BY-STEP METHOD DETAILS
Figure 2 shows an overall schematic of the workflow.Preparing Xenopus Egg Extracts
Timing: 2 h
Prepare egg extracts from different frog species (X.l., X.b., and X.t.).
Extract preparation is a time-sensitive process requiring constant vigilance. An experienced
researcher can handle 5–6 batches of eggs at the same time. For scaling up, we suggest involving
multiple lab members. We recommend preparing extracts in a temperature-controlled lab-space
maintained between 18C–20C.
CRITICAL: For X.t. extract preparation, all glass and plastic-ware must be coated by swirl-ing a 0.2% gelatin % (w/v) solution in the beakers. Discard gelatin solution from beakers
after use.1. Collect laid eggs in a 0.8 or 1 L glass beaker (Figure 3A) and keep batches separate if possible.STAR Protocols 1, 100151, December 18, 2020 13
Figure 2. Overall Schematic Workflow
For each stage (dotted box), steps are annotated.
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OPEN ACCESS ProtocolNote: For X.l., the frogs are kept in 13 MMR during egg laying. X.b. frogs on the other hand
are kept in 0.53 MMR. X.t. frogs are kept in tank water, but eggs are collected in 13 MMR.
Both laid and squeezed eggs from each species can be used for extract preparation.
2. Pour off any residual buffer/water and wash the eggs several times in 13 MMR (0.53 MMR for
X.b.).
3. With the help of a Pasteur pipette remove lysed and puffy eggs (Figure 3B).
CRITICAL: The quality of eggs is important and can impact the yield and quality of proteinobtained. Sorting out puffy and lysed eggs (Figure 3B) should thus be performed meticu-
lously. Additionally, we suggest discarding any batch of eggs with more than 10% of total
eggs lysed or activated.4. Pour off the MMR and add Dejelly Buffer.
5. Gently swirl the beaker to ensure uniform dejellying. As the dejellying successfully progresses,
the eggs become more densely packed.
6. Exchange the solution after 2.5 min and wash again with fresh Dejelly Buffer.
7. Upon successful dejellying, the eggs pack tightly (Figure 3D).
CRITICAL: Ensure that the dejellying step is no longer than 5–6 min (10 min for X.t. eggs).Excessive dejellying may damage the eggs and cause lysis.8. Pour off as much Dejelly Buffer as possible while ensuring that the eggs are not exposed to air.
9. Add CSF-XB to the beaker and gently swirl the eggs. CSF-XB addition halts the dejellying
reaction.
CRITICAL: Dejellied eggs are particularly sensitive to mechanical perturbations. Specialcare must thus be taken during the following steps.14 STAR Protocols 1, 100151, December 18, 2020
Figure 3. Preparing Xenopus Egg Extract
(A) Good-quality Xenopus laevis eggs.
(B) Lysed and puffy eggs (in red squares).
(C) Sorted eggs that have been washed with MMR Buffer.
(D) After successful dejellying, eggs are densely packed.
(E) Eggs transferred into a suitable centrifuge tube.
(F) After a short low-speed spin eggs are tightly packed.
(G) A subsequent high-speed spin is used to crush the eggs and fractionate them into different layers: layer I is
enriched in lipids, layer II is critical as it contains all cytoplasmic proteins including tubulin and layer III contains a
mixture of pigment granules, yolk, nuclei, and egg cortex.
(H) With the help of a syringe and 18G needle, layer II is extracted.
ll
OPEN ACCESS
STAR Protocols 1, 100151, December 18, 2020 15
Protocol
ll
OPEN ACCESS Protocol10. Decant the CSF-XB and wash 2–3 times with CSF-XB Buffer.
11. Exchange the CSF-XB for CSF-XB+ buffer (CSF-XB containing protease inhibitor) and gently
swirl.
12. Preload an ultracentrifuge tube with 1 mL of CSF-XB+ buffer and 10 mL of Cytochalasin D
(10 mg/mL) (X.l. and X.b.). For X.t. eggs add 1 mL of CSF-XB+ and 5 mL of Cytochalasin D.
13. Carefully load eggs into the tube with the help of a cut plastic Pasteur pipette.
Note: Ensure that while transferring eggs into the tube they are not exposed to air and try to
fill the tube all the way to the top (Figure 3E). If eggs from different batches appear healthy up
to this step, they can bemixed to ensure centrifuge tubes are filled completely. Full tubes pro-
vide better separation during the crushing spin.
14. Transfer the ultracentrifuge tube into a polypropylene tube with the help of forceps. The poly-
propylene tube acts as an adaptor that fits most clinical centrifuges (Eppendorf, Sorvall, etc.).
Note: Place a few drops of buffer into the polypropylene adaptor before transferring the tube
containing eggs to ensure the tube does not stick to the adaptor after the spin.
15. Packing spin: Transfer tubes to clinical centrifuge set to 18C (X.l., X.b.) or 16C (X.t.). Spin X.l.
and X.b. eggs at 500 rpm for 30 s, followed by 2,000 rpm for 90 s. X.t. eggs are spun at 200 rpm
for 30 s, followed by 800 rpm for 90 s.
16. After this spin, eggs should appear tightly packed (Figure 3F).
17. Remove any residual buffer on top of the eggs.
CRITICAL: It is important to remove any residual buffer from the top of the eggs. At thisstep it is okay to sacrifice some of the eggs by exposing them to air, as any residual buffer
will dilute the extract.18. Crushing spin: Transfer the tubes into rubber adaptors. Spin at 11,000 rpm in a JS-13.1 swinging
bucket rotor (19,000 3 g) for 20 min.
CRITICAL: Centrifugation should start at room temperature or 18C. For X.l. egg extracts,
the centrifuge should cool down during the spin to reach 4C. For X.b. and X.t. egg ex-
tracts, the temperature can stay at constant 16C–18C. Extracts are also temperature sen-
sitive and the correct temperature must be maintained to ensure proper biochemical activ-
ity. The acceleration settings for the centrifuge are set to maximum. The deceleration step
is set to slow and the brake is turned off.19. Remove the thin-wall tube with the fractionated eggs from the polypropylene adaptor.
20. After the crushing spin, the eggs should separate into three distinct layers (Figure 3G). The top
layer is enriched in lipids. The second golden layer is the cytoplasmic layer and contains all sol-
uble cytoplasmic proteins. The final dark layer contains a mixture of pigment granules, yolk, and
egg cortex.
CRITICAL: All equipment used to handle extracts should be kept at the appropriate tem-perature. For X.l. and X.b. extracts, syringes, needles, forceps, tubes, etc. should be kept
on ice. For X.t. extracts, equipment can be kept between 16C–20C.21. With the help of a syringe and 18G-needle, puncture the tube near the bottom of the cyto-
plasmic layer (Figure 3H), rotate the needle so that the opening faces up and and gently aspirate
the cytoplasmic fraction.
22. Remove the needle and gently expel the extract into an Eppendorf tube.16 STAR Protocols 1, 100151, December 18, 2020
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of X.l. and X.b. egg extract on ice and X.t. egg extract at 16C. Extract can be used for 6–
8 h without significant loss of activity.23. Add Cytochalasin D (1:1,000) and protease inhibitors (1:100) to the X.l. extract. To X.b. and X.t.
extract, add Cytochalasin D (1:500) and protease inhibitors (1:200).
24. Gently mix the extract with the help of a cut pipette tip.
Optional: Take a western blot sample of your extract for quality control (see tubulin post-trans-
lational modifications).
CRITICAL: We recommend proceeding to the tubulin purification step immediately.Extract should not be frozen at this point, as this will impact tubulin activity.TOG Affinity Purification of Tubulin from Xenopus Egg Extract
Timing: 6 h from clearing extracts to frozen aliquots of purified tubulin
Perform all following steps in a cold room or on ice. Pre-chill all buffers, containers, columns etc.
Note: As a reference we will use a total of 4 mL egg extract and a 5 mL TOG column. Yields for
the various purifications are shown in Table 1.
25. Dilute egg extract 1:1 with 13 BRB80 to a final volume of 8 mL.
26. Take a 10 mL sample ‘‘lysate’’ for SDS-PAGE and western blot analysis.
27. Add 3 mL benzonase (25 U/mL) and DTT to 1 mM final concentration and mix carefully by slowly
pipetting up and down with a cut pipette tip.
28. Split the diluted egg extract into two ice-cold polycarbonate ultracentrifuge tubes and adjust to
equal weight by adding small drops of 13 BRB80.
29. Centrifuge at 80,000 rpm (440,000 3 g) in a pre-cooled MLA-80 rotor at 2C for 30 min.
Note: After the spin, the extract should be clear. If this is not the case, you can further clear the
lysate by passing it through a 0.45 mm filter. In case a layer formed on top of the cleared
extract, collect the lysate carefully with a syringe and a needle.
30. Take a 10 mL sample of ‘‘HS spin’’ for SDS-PAGE and western blot analysis.
31. During the spin, assemble the purification setup in the cold room.
32. Wash tubing with 20% ethanol.
33. Wash tubing with ultra-pure water.
34. Wash tubing with wash buffer.
35. Connect the TOG column to the peristaltic pump and tubing and equilibrate the TOG column
with 10 CV 13 BRB80 at a flow rate of 1 CV/min.
CRITICAL: Be careful not to introduce air bubbles into the TOG column when connectingthe tubing, otherwise you compromise TOG activity. If you happen to have air bubbles in
the tubing, disconnect the tubing from TOG column and pump wash buffer through the
tubing until the air bubbles are out of the system, then reconnect to the TOG column care-
fully. Never let the TOG column run dry.36. Cycle the cleared lysate through the TOG column at a flow rate of 0.5 CV/min for 20 min.
37. Take a 10 mL sample of ‘‘flow-through’’ for SDS-PAGE and western blot analysis.
38. Wash with 2 CV wash buffer to clear out most of the extract from the TOG column.STAR Protocols 1, 100151, December 18, 2020 17
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40. Change the flow rate to 1 CV/min and wash with 10 CV wash buffer.
41. Take a 100 mL sample of ‘‘wash 2’’ for SDS-PAGE and western blot analysis.
42. Wash with 3 CV ATP wash buffer.
43. Take a 100 mL sample of ‘‘ATP wash’’ for SDS-PAGE and western blot analysis.
44. Incubate for 15 min.
45. Wash with 3 CV ATP wash buffer.a. Meanwhile you can start equilibrating the PD-10 desalting columns 33 with ice-cold desalt-
ing buffer.
Note: Each PD-10 column can hold 2.5 mL of eluted tubulin and 3.5 mL desalting buffer are
used to elute it from the column. We usually calculate to have a maximum of 10 mL of pooled
tubulin fractions, so we calibrate a total of 4 PD-10 columns.
46. Take a 100 mL sample of ‘‘wash 4’’ for SDS-PAGE and western blot analysis.
47. Wash with 10 CV wash buffer.
48. Take a 100 mL sample of ‘‘wash 5’’ for SDS-PAGE and western blot analysis.
Note: At this step, there should not be any protein in your washes. You can check this wash for
the presence of proteins either by Bradford assay or A280. If you detect protein, additionally
wash with 4 CV wash buffer. Take a 100 mL sample of ‘‘wash 6’’ for SDS-PAGE and western
blot analysis.
49. Decrease flow rate to 0.25 CV/min and elute tubulin with 3 CV elution buffer into 153 1 mL
fractions.
50. Check each fraction for protein by using a Bradford assay or A280.
51. Pool the fractions with the highest protein concentration.
CRITICAL: Take care to limit exposure of the tubulin to high salt since this will compromisetubulin activity over time. Quickly desalt the pooled fractions into desalting buffer using
the PD-10 columns.52. Take a 10 mL sample of ‘‘pooled peak elutions’’ for SDS-PAGE and western blot analysis.
53. Desalt pooled fractions via the PD-10 columns using ice-cold desalting buffer.
54. Equilibrate one 4 mL Amicon Ultra-4 concentration column with desalting buffer by spinning it
23 for 3 min at 4,000 rpm (3,220 3 g) in a clinical centrifuge at 2C.
CRITICAL: The concentration step is the most critical in our hands. In some cases, we havelost up to 30% protein during this step. To minimize loss, we recommend thoroughly equil-
ibrating the concentration column with desalting buffer and avoiding long spinning pe-
riods (See also Troubleshooting).55. Concentrate the tubulin to at least 20 mM using a 4 mL Amicon Ultra-4 concentration column by
spinning in a clinical centrifuge at 4,000 rpm (3,220 3 g) at 2C.
Note: A 4 mL Amicon Ultra-4 concentration column allows you to concentrate to a minimum
volume of 500 mL. In case you want to concentrate further, we recommend switching to a
smaller concentration column with a maximum capacity of 0.5 mL.
56. Take a 2 mL sample of ‘‘desalted and concentrated’’ for SDS-PAGE and western blot analysis.
57. Once tubulin is concentrated to your desired concentration, measure the final protein concen-
tration, flash-freeze in liquid nitrogen and store at 80C. We usually use PCR tubes and make
5 mL aliquots.18 STAR Protocols 1, 100151, December 18, 2020
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115,000 M1 cm1 and MW= 110 kDa).
58. Clean the TOG column by washing with 5 CV 13 PBS at 1 CV/min.
Note: Ideally the TOG column is cleaned directly after use. We usually clean it during the con-
centration step.
59. Lower the flow rate to 0.5 CV/min and wash with 10 CV 103 PBS.
60. Wash with 10 CV column storage buffer.
61. Cap column tightly without introducing air bubbles and store in a 50 mL Falcon tube at 20C.
62. Proceed with SDS-PAGE and western blot analysis for quality control.EXPECTED OUTCOMES
This protocol allows for the purification of pure and highly concentrated active tubulin. To document
and ensure the quality of each purification step, we usually take a number of quality control steps: (1)
SDS-PAGE and Coomassie stain of the tubulin purification process, (2) SDS-PAGE and western blot
analysis against a-tubulin of the tubulin purification process, (3) SDS-PAGE and western blot analysis
against different post-translational modifications of extract and purified tubulin to show the tubulin’s
post-translational modification pattern was conserved throughout the purification, (4) in-solution
digest and mass spectrometry to assess tubulin purity, (5) polymerization assay to test tubulin activ-
ity, (6) reconstitution of microtubule dynamics in vitro by TIRF.SDS-PAGE and Western Blot Analysis of a-Tubulin
To determine the effectiveness of the affinity purification, resolve the samples taken during the pu-
rification via SDS-PAGE and stain the gel with Coomassie (Figure 4A). Load sample volumes corre-
sponding to 1 mL extract from each step in order to determine tubulin loss during the spin, in the











10. Pooled peak elutions
11. Desalted and concentrated
In the Coomassie, lanes 5–9 should not contain substantial amounts of protein. Lanes 10 and 11
should not contain any other protein than tubulin, which migrates as a closely spaced doublet at
55 kDa. Bands that run lower than 55 kDa are most likely tubulin degradation products, which will
also appear in the western blot analysis.
In a second step, we analyse the same samples by western blot (Figure 4B) using a pan-specific anti–
a-tubulin monoclonal antibody (DM1a). Here, lanes 1 and 2 should contain comparable amounts of
tubulin, indicating no substantial tubulin loss during the high-speed spin. Importantly, lane 3 should
not contain any tubulin, indicating a complete depletion of tubulin from the lysate and thus no
enrichment of a tubulin subpopulation, e.g., a specific isoform or post-translational modification.STAR Protocols 1, 100151, December 18, 2020 19
Figure 4. Coomassie Staining and Western Blot Analysis of the Tubulin Purification
(A) Coomassie-stained SDS-PAGE of samples taken during the purification of tubulin. (1) Lysate; (2) HS spin; (3) Flow-
through; (4) 1st wash; (5) 2nd wash; (6) ATP wash; (7) 4th wash; (8) 5th wash; (9) 6th wash; (10) Pooled elutions; (11)
Desalted and concentrated tubulin.
(B) Western blot with antibody against a-tubulin of the same samples as in (A).
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To make sure that the purification did not change the tubulin’s post-translational modification
pattern, we probe extract tubulin (sample taken at step 26) and purified tubulin (sample taken at
step 56) by western blot using antibodies against a-tubulin as loading control, tyrosinated tubulin
(Tyr), detyrosinated tubulin (Detyr), acetylated lysine 40 (K40), and phosphoserine (P-Ser)
(Figure 5A).Tubulin In-Solution Digest and Mass Spectrometry
Tubulin sample purity can be evaluated by LC-MS/MS analysis of in-solution tryptic digests of the
purified tubulin. We use the emPAI (Exponentially Modified Protein Abundance Index) value to es-
timate the relative abundance of the proteins in our sample. Tubulin usually is of high purity (> 98%).
If additional proteins are identified, they mainly include highly abundant proteins like heat shock
proteins or ribosomal proteins. There should not be any contamination with microtubule associated
proteins (MAPs) or motor proteins, as these will influence microtubule dynamics in your downstream
experiments.Polymerization Assay
For any tubulin purification, it is essential to confirm that the purified protein is polymerization-
competent. The simplest way to do this is a tubulin polymerization assay. Purified tubulin (e.g.,
20 mM) is induced to polymerize in 13 BRB80 buffer in the presence of 1 mM GTP and 33% v/v glyc-
erol at 35C for 40 min. The reaction is layered on top of an equal volume of 13 BRB80 containing
60% glycerol, and centrifuged in a TLA-100 rotor at 35C for 10 min at 80,000 rpm (280,000 3 g).
Polymerized microtubules form the pellet, whereas non-polymerized tubulin remains in the reaction
mixture above the 60% glycerol layer. Relative tubulin abundance in the input, supernatant, and pel-
let fractions are assessed by SDS-PAGE and western blot analysis. Most of the total tubulin (>90%)
should be found in the pelleted polymer fraction (Figure 5B).
Note: Tubulin concentration and assay temperature for microtubule polymerization will
dependent on the source of the purified tubulin. X. laevis tubulin will readily polymerize at
20C and 10 mM, while conventional bovine brain tubulin will not.
This polymerization assay, however, cannot distinguish between tubulin assembled into microtu-
bules or sheets. To determine whether the affinity-purified tubulin forms microtubules that undergo
dynamic instability, we recommend reconstituting dynamic microtubules in vitro and visualizing
them by TIRFM or IRM.20 STAR Protocols 1, 100151, December 18, 2020
Figure 5. Posttranslational Modifications and Activity of Purified Tubulin
(A) Western blot against tubulin PTMs before and after the purification. 300 ng tubulin for each species (Bos taurus,
Xenopus laevis, Xenopus tropicalis) were loaded onto a polyacrylamide gel adjacent to a corresponding volume of
egg extract. Samples were transferred to a nitrocellulose membrane and probed with antibodies against a-tubulin,
tyrosinated tubulin (Tyr), detyrosinated tubulin (Detyr), acetylated lysine 40 (K40), and phosphoserine (Pser).
(B) Tubulin polymerization assay for assessing the relative activities of bovine brain tubulin and Xenopus tubulin
purified via the TOG column. 2 mL of the 20 mM initial reaction mixture was loaded onto the gel as the input (I), followed
by equivalent volumes for the supernatant (S) and the pellet (P) after resuspending the pellet in the same starting
volume of 13 BRB80.
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The final amount of tubulin will mainly depend on the following three factors:
(1) The total amount of tubulin in your starting material/lysate,
(2) tubulin binding to TOG column depending on its binding capacity,
(3) efficiency of tubulin elution, desalting, and concentration.
We usually start with a back-of-the-envelope calculation to estimate the tubulin present in our start-
ing material. For Xenopus egg extracts, we recommend using a minimum of 2 mL of egg extract to
purify enough tubulin for downstream functional assays. The binding capacity of the TOG column
will depend on the number of immobilized TOG1/2 domains, and each TOG1/2 will bind one tubulin
heterodimer (Brouhard et al., 2008, Widlund et al., 2011). Finally, the efficiency of tubulin binding,




Frogs have not laid enough eggs or eggs of poor quality.
Potential Solution
If the frogs have not laid enough eggs before the start of the experiment, we suggest waiting a few
hours and delaying the entire purification process. In our experience, giving the frogs a gentle
squeeze can help accelerate the egg-laying process. Additionally, frogs can lay a second batch of
eggs several hours after the first batch has been laid. Priming the frogs maximizes the chances of
ovulation, increases egg yield, and improves egg quality. Frogs should be given a 3-month recovery
period between ovulations.
Problem
No distinct layers after crushing spin.
Potential Solution
For the crushing spin, make sure to set the acceleration tomaximum, the deceleration to slow, and to
turn the brake off. For X.l. eggs, starting with a rotor at room temperature and only cooling down
during the spin improves layer separation.STAR Protocols 1, 100151, December 18, 2020 21
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Extract is too dilute.
Potential Solution
Ensure that most of the buffer is removed while exchanging solutions during the extract preparation.
Also remove any buffer left on top of the eggs after the packing spin. Any residual buffer left will
dilute the concentration of proteins in the extract. Final egg extract concentration should be
100 mg/mL (Groen et al., 2011).
Problem
There is tubulin in the flow-through.
Potential Solution
This unbound fraction may represent (1) denatured tubulin, (2) saturation of the TOG column or (3) a
decrease in binding capacity of the TOG column. The best way to distinguish between these three
potential problems, is to load a known amount of tubulin onto the TOG column and analyse how
much is recovered.
Problem
You lose most of your tubulin during the concentration step.
Potential Solution
Tubulin concentration should be determined before and after concentrating to determine concen-
tration efficiency and potential protein loss. To minimize non-specific adsorption of protein to the
walls and filter, equilibrate the concentration column as described in step 54. Centrifuge the concen-
tration column for no longer than 10 min at a time. Longer spins allow precipitated protein resulting
from an increased local concentration above the membrane to build up and block the flowthrough.
Carefully resuspend any precipitates, which could contain functional polymerized tubulin, and rinse
the membrane three times with the remaining protein solution between spins. At the end of the con-
centration step, take out the concentrated tubulin and rinse the concentration column including the
membrane with a minimal volume of desalting buffer to recover any residual tubulin. Take care at all
times to avoid touching and damaging the filter membrane.
Problem
The tubulin yield is much lower than expected.
Potential Solution
This can result from multiple factors. Make sure to use appropriate amounts of starting material.
Furthermore, check whether and how efficiently tubulin did bind to the TOG column, which will
become evident when doing the quality control. Make sure to not lose most of the tubulin during
the concentration step.
Problem
The tubulin does not polymerize using standard tubulin polymerization protocols.
Potential Solution
For tubulin purifications from different species, you might need to test a variety of polymerization
methods to find a suitable condition promoting microtubule growth. Critical concentration and tem-
perature are particularly important parameters to consider. For example, at 37, X. laevis tubulin will
polymerize at concentrations as low as 1.5 mM, whereas bovine brain tubulin will not. Assembling
microtubules in the presence of a microtubule-stabilizing drug such as Taxol will help demonstrate
that the tubulin is indeed functional, even if optimal growth conditions have not yet been estab-
lished. Another problem might be hydrolyzed GTP, in which case use a fresh aliquot of GTP.22 STAR Protocols 1, 100151, December 18, 2020
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A major portion of the purified tubulin is inactive.
Potential Solution
Soluble tubulin will lose activity over time, even if kept on ice or at 4C. Take care to avoid delays
between steps of the protocol, especially when the tubulin is in the high-salt elution buffer.
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